Ouyang, Xuenong
Shi, Meiqi
Jie, Fangwei
Bai, Yuxian
Shen, Peng
Yu, Zhuang
Wang, Xiuwen
Huang, Cheng
Tao, Min
Wang, Zhehai
Xie, Conghua
Wu, Qi
Shu, Yongqian
Han, Baohui
Zhang, Fengchun
Zhang, Yiping
Hu, Chunhong
Ma, Xitao
Liang, Yongjie
Wang, Anlan
Lu, Bing
Shi, Yi
Chen, Jinfei
Zhuang, Zhixiang
Wang, Jiejun
Huang, Jianjin
Wang, Changhui
Bai, Chunxue
Zhou, Xin
Li, Qiang
Chen, Feng
Yu, Hao
Feng, Jifeng
Funding for this research was provided by:
Shanghai biomedical technology fund (08431901100)
National sme funding fund (10C26213100701)
National major science and technology project fund (2010ZX09401-301)
Article History
Received: 13 July 2017
Accepted: 30 October 2017
First Online: 14 November 2017
Compliance with ethical standards
:
: All authors received research funding from Gebaide Biotechnology Co., Ltd. for conducting the study and preparing this report. No potential conflicts of interest were disclosed.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all individual patients included in the study.